Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study.

ABSTRACT:

SUBMITTER: Platzbecker U 

PROVIDER: S-EPMC3677141 | biostudies-literature | 2013 Jun

REPOSITORIES: biostudies-literature